Abstract

Dr. Jaynarayan Sharma*, Dr. Ashok Kumar Madan Singh, Dr. Aayushi Shrivastav

ABSTRACT

Hypertension, or high blood pressure, represents a significant global health issue linked to cardiovascular diseases, strokes, and kidney problems. Often referred to as a silent killer, it plays a crucial role in global morbidity and mortality rates. In the context of Ayurveda, hypertension is associated with Vyana Bala Vaishamya, a condition characterized by imbalances in Vyana Vata and its interactions with the Pitta and Kapha Doshas. This review examines the therapeutic potential of a combined treatment approach utilizing Sarpagandha Vati and Anuloman Chikitsa with Haritaki Churna for hypertension management. Sarpagandha Vati, sourced from the plant Rauwolfia serpentina, has a longstanding history in Ayurvedic practice for its ability to lower blood pressure and its sedative effects, primarily attributed to its alkaloids, such as reserpine. Anuloman Chikitsa facilitates healthy bowel movements and detoxification, assisting in the balancing of Vata Dosha and the elimination of metabolic waste. Haritaki Churna, derived from Terminalia chebula, is recognized as a Rasayana with antioxidant, antiinflammatory, and mild diuretic effects, contributing to hypertension management and supporting overall cardiovascular and digestive well-being. A comprehensive review of classical Ayurvedic literature and modern clinical studies has been undertaken to substantiate the effectiveness of these interventions. Research indicates that the synergistic application of these therapies may aid in blood pressure regulation, enhance circulation, alleviate stress, and facilitate detoxification, subsequently lowering the risk of complications associated with hypertension. Future studies should concentrate on large-scale clinical trials to further confirm their significance in integrative medicine approaches.